Cambrex to acquire Snapdragon Chemistry!




East Rutherford, NJ (November 21, 2022) – Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.


"Partnering our best-in-class process development capabilities with Cambrex’s larger scale manufacturing facilities in North America and Europe is a natural fit, both for our employees and our customers." -Matt Bio, CEO of Snapdragon Chemistry



Read the Full Press Release Below



118 views0 comments